Silver Book Fact

An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment and caregiver-support programs; the greatest benefits with a combination of both.

Weimer D, Sager M. Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes. Alzheimers Dement. 2009; 5(3): 215-26. http://www.alzheimersanddementia.com/article/S1552-5260(09)00029-6/abstract

Reference

Title
Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes
Publication
Alzheimers Dement
Publication Date
2009
Authors
Weimer D, Sager M
Volume & Issue
Volume 5, Issue 3
Pages
215-26
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The present value QUALY gains associated with a new drug that by 2010 could delay disease onset by 1, 3, and 5 years. The dollar value estimates range from approximately…  
  • Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.  
  • “A treatment breakthrough that delayed the age of onset of Alzheimer’s disease by five years and began to show its effects in 2015 would decrease the total number of Americans…  
  • Impact of a 5-Year Delay in Onset on Costs, Americans Age 65 and Older with Alzhemier’s Disease, 2010-2050  
  • Research shows that use of donepezil leads to a 4-fold increase in drug costs; however, it significantly lowers overall medical costs, reducing medical treatment and prescription drug costs by $3,891…